Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...
Naïve CD8 T cells can change into different types of effector and memory CD8 T cells when the immune system responds to ...
A team has developed scSPOT, a new technique that reveals how immune cells called Tregs simultaneously control the immune system. The team identified key immune cells controlled by Tregs and found ...
FP008 is designed for patients with solid tumors that have not responded to existing immunotherapies targeting PD-1.
The U.S. Food and Drug Administration (FDA) has approved Fapon Biopharma’s Investigational New Drug (IND) application for ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Medicenna Therapeutics (MDNA) announced the presentation of new clinical data from its ongoing ABILITY-1 study evaluating MDNA11 alone or in ...
The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with ...
The leading Cutaneous Squamous Cell Carcinoma Companies such as Incyte Corporation, Shanghai Henlius Biotech, Novartis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback